Evaxion Biotech AS (EVAX)
2.64
+0.05
(+1.93%)
USD |
NASDAQ |
Nov 04, 16:00
2.64
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech Market Cap: 14.72M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 14.44M |
| October 31, 2024 | 14.89M |
| October 30, 2024 | 15.39M |
| October 29, 2024 | 16.23M |
| October 28, 2024 | 15.84M |
| October 25, 2024 | 15.39M |
| October 24, 2024 | 14.78M |
| October 23, 2024 | 14.89M |
| October 22, 2024 | 14.27M |
| October 21, 2024 | 14.16M |
| October 18, 2024 | 14.72M |
| October 17, 2024 | 15.11M |
| October 16, 2024 | 15.11M |
| October 15, 2024 | 14.50M |
| October 14, 2024 | 15.00M |
| October 11, 2024 | 14.50M |
| October 10, 2024 | 14.67M |
| October 09, 2024 | 14.94M |
| October 08, 2024 | 15.84M |
| October 07, 2024 | 15.89M |
| October 04, 2024 | 16.45M |
| October 03, 2024 | 17.06M |
| October 02, 2024 | 16.62M |
| October 01, 2024 | 16.34M |
| September 30, 2024 | 17.34M |
| Date | Value |
|---|---|
| September 27, 2024 | 17.40M |
| September 26, 2024 | 17.06M |
| September 25, 2024 | 15.78M |
| September 24, 2024 | 16.56M |
| September 23, 2024 | 16.45M |
| September 20, 2024 | 16.67M |
| September 19, 2024 | 17.56M |
| September 18, 2024 | 17.40M |
| September 17, 2024 | 16.90M |
| September 16, 2024 | 18.12M |
| September 13, 2024 | 16.73M |
| September 12, 2024 | 17.06M |
| September 11, 2024 | 17.51M |
| September 10, 2024 | 17.84M |
| September 09, 2024 | 18.12M |
| September 06, 2024 | 19.24M |
| September 05, 2024 | 17.96M |
| September 04, 2024 | 19.01M |
| September 03, 2024 | 17.62M |
| August 30, 2024 | 17.01M |
| August 29, 2024 | 18.57M |
| August 28, 2024 | 16.78M |
| August 27, 2024 | 17.79M |
| August 26, 2024 | 17.17M |
| August 23, 2024 | 17.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
12.82M
Minimum
Aug 08 2024
243.44M
Maximum
Nov 04 2021
61.01M
Average
42.79M
Median
May 17 2022
Market Cap Benchmarks
| Ascendis Pharma AS | 7.510B |
| Novo Nordisk AS | 488.22B |
| DBV Technologies SA | 75.33M |
| Adaptimmune Therapeutics PLC | 210.89M |
| Akari Therapeutics PLC | 28.93M |
Market Cap Related Metrics
| PS Ratio | 3.658 |
| Price to Book Value | 199.00 |
| Price | 2.64 |
| Earnings Yield | -106.1% |